Patenting AI in Europe in the Age of Generative AI

Watch Keltie’s Directors, Kimberley Bayliss and Colin Paterson, and Partner, Mark Richardson, deep-dive into Generative-AI.

This webinar provides updates on:

The technology behind the Generative Pre-trained Transformer (GPT) models that have driven the sudden explosion in AI seen in recent months.
How GPT models might be incorporated into different inventions and the patentability of each invention type at the EPO.
Recent case-law updates related to sufficiency, inventive step and patentability of AI inventions.
The UPC, Designs and Copyright and the impact of the EU AI Act on patenting AI inventions.

Continue reading about Patenting AI in Europe in the Age of Generative AI

Kimberley Bayliss

About the author More from the author

06.08.2024

CRISPR patent battle update

Last year, we published an article looking at some of the IP issues raised by CRISPR-Cas9 gene-editing technology. One of these issues concerned the battles over the ownership of certain fundamental patents.

19.06.2024

Q&A with Michael Moore: Leading innovations in biotechnology and intellectual property

Keltie features again in the Financial Times' prestigious list of Europe's Leading Patent Law Firms 2024. Keltie is one of the leading firms of IP specialists in Europe and is recognised by its peers across several core areas. We talk to Mike to discover what makes a successful IP firm and how biotechnology is evolving. He discusses his journey into the field and talks about all things ‘AI’.